RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Clearpoint Neuro Stock

Clearpoint Neuro ROA 2024

Clearpoint Neuro ROA

-0.52

Ticker

CLPT

ISIN

US18507C1036

WKN

A2PZ3E

In 2024, Clearpoint Neuro's return on assets (ROA) was -0.52, a 74.77% increase from the -0.3 ROA in the previous year.

Clearpoint Neuro Aktienanalyse

What does Clearpoint Neuro do?

Clearpoint Neuro Inc is a leading company in the medical technology industry that specializes in the development and marketing of advanced medical products and systems. The company was founded in 1998 and is headquartered in Irvine, California. Clearpoint Neuro's primary goal is to provide better care and treatment for patients with neurological disorders. Clearpoint Neuro was originally founded in 1998 under the name MRI Intervention to meet the market demand for innovative navigation systems for minimally invasive brain procedures. The company's initial products included imaging devices used during surgery. Since then, the company has expanded its product portfolio and strengthened its market position by focusing on core tasks in the field of medical technology. In 2011, MRI Intervention rebranded as Clearpoint Neuro to accommodate its growing product portfolio. The company now primarily focuses on the development and marketing of platform technologies for the control of minimally invasive instruments during neurosurgical procedures. Its customers include hospitals and research institutions that specialize in neurological and neuroscience applications. Clearpoint Neuro has built an extremely successful business model that specializes in providing advanced medical technology to benefit patients. The company works closely with leading neurosurgeons and researchers to understand the needs of patients and develop the most advanced technologies aimed at improving patient treatment. Clearpoint Neuro is a B2B (Business to Business) company that sells its products and services to hospitals and research institutions to ensure that its products are used by medical professionals with appropriate education and experience. The company also has a strong presence in the academic world, where it focuses on collaborating with laboratories and universities to advance the latest developments in technology and research. The divisions of Clearpoint Neuro include medical product areas developed from its technology base, which are described in more detail in the following sections. ClearPoint System ClearPoint is an intraoperative MRI system that is available as a core component of neurosurgical intervention platforms. It uses advanced technology for real-time localization and navigation of instruments to perform minimally invasive brain surgeries. It utilizes imaging technologies to enable navigation and coordination during the surgical procedure. ClearPoint Neuro Therapies ClearPoint Neuro Therapies includes three main areas: "DBS," "MRI-Guided Focused Ultrasound," and "Laser Therapy." DBS (Deep Brain Stimulation) is a minimally invasive neural therapy that involves the insertion of thin electrodes into the brain using a specially existing surgical technique to treat degenerative diseases, particularly Parkinson's disease. Another highly innovative therapy option is MRI-Guided Focused Ultrasound therapy, which targets and precisely destroys cancer cells using focused ultrasound waves. ClearPoint Neuro is one of the leading providers of this advanced therapy. Laser therapy involves the destruction of selected neural cells using heat. ClearPoint Neuro Navigation ClearPoint Neuro's navigation technologies are leading in neurosurgery and research. Navigation allows for precise placement of needles in the brain to obtain biopsies under ultrasound guidance or to administer medication targetedly without damaging the brain. The system is used by neurosurgeons and researchers worldwide. In conclusion, Clearpoint Neuro Inc is a leading company in the medical technology industry that specializes in the development and manufacturing of advanced systems and products for neurosurgery and research. The company has built a strong business model by working closely with leading neurosurgeons and researchers and developing the most advanced technologies aimed at improving the quality of patient care. The ClearPoint System, ClearPoint Neuro Therapies, and ClearPoint Neuro Navigation divisions play a significant role in its success. Clearpoint Neuro ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Clearpoint Neuro's Return on Assets (ROA)

Clearpoint Neuro's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Clearpoint Neuro's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Clearpoint Neuro's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Clearpoint Neuro’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Clearpoint Neuro stock

What is the Return on Assets (ROA) of Clearpoint Neuro this year?

The Return on Assets (ROA) of Clearpoint Neuro is -0.52 undefined this year.

What was the ROA of Clearpoint Neuro compared to the previous year?

The ROA of Clearpoint Neuro has increased by 74.77% compared to the previous year.

What consequences do high ROA have for investors of Clearpoint Neuro?

A high ROA is advantageous for investors of Clearpoint Neuro, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Clearpoint Neuro?

A low ROA can be unfavorable for investors of Clearpoint Neuro as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Clearpoint Neuro affect the company?

An increase in ROA of Clearpoint Neuro can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Clearpoint Neuro impact the company?

A reduction in the ROA of Clearpoint Neuro can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Clearpoint Neuro?

Some factors that can influence the ROA of Clearpoint Neuro include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Clearpoint Neuro important for investors?

The ROA of Clearpoint Neuro is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Clearpoint Neuro take to improve ROA?

To improve ROA, Clearpoint Neuro can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Clearpoint Neuro pay?

Over the past 12 months, Clearpoint Neuro paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Clearpoint Neuro is expected to pay a dividend of 0 USD.

What is the dividend yield of Clearpoint Neuro?

The current dividend yield of Clearpoint Neuro is .

When does Clearpoint Neuro pay dividends?

Clearpoint Neuro pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Clearpoint Neuro?

Clearpoint Neuro paid dividends every year for the past 0 years.

What is the dividend of Clearpoint Neuro?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Clearpoint Neuro located?

Clearpoint Neuro is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clearpoint Neuro kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clearpoint Neuro from 7/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/11/2024.

When did Clearpoint Neuro pay the last dividend?

The last dividend was paid out on 7/11/2024.

What was the dividend of Clearpoint Neuro in the year 2023?

In the year 2023, Clearpoint Neuro distributed 0 USD as dividends.

In which currency does Clearpoint Neuro pay out the dividend?

The dividends of Clearpoint Neuro are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Clearpoint Neuro

Our stock analysis for Clearpoint Neuro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clearpoint Neuro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.